This comprehensive review highlights the diverse mechanisms underlying diabetic nephropathy, focusing on the interplay of metabolic, hemodynamic, and inflammatory factors. It discusses current diagnostic strategies, risk stratification, and emerging therapeutic interventions, including SGLT2 inhibitors and GLP-1 receptor agonists, to slow disease progression and prevent end-stage renal disease in patients with diabetes.
